---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-043364"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T17:41:28.723681+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Oscar Health reaffirms FY2025 guidance at Raymond James conference

## Summary
- Company participates in 2025 Raymond James Institutional Investors Conference on March 3.
- Reaffirms full year 2025 guidance originally provided on Feb 4, 2025 in Q4 2024 earnings release.
- No new financial information or changes disclosed in this filing.

## SEC filing metadata
- accession: 0001193125-25-043364
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000119312525043364/0001193125-25-043364-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000119312525043364/d922311d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-043364
- JSON: https://secwatch.observer/filing/0001193125-25-043364.json
- Plain text: https://secwatch.observer/filing/0001193125-25-043364.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.